PIM1 anticorps (pTyr309)
-
- Antigène Voir toutes PIM1 Anticorps
- PIM1 (Pim-1 Oncogene (PIM1))
-
Épitope
- pTyr309
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PIM1 est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- The antibody detects endogenous levels of Pim-1 only when phosphorylated at tyrosine 309.
- Purification
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
- Immunogène
- Pim-1 (phospho Tyr309) antibody was raised against a peptide sequence around phosphorylation site of tyrosine 309 (A-A-V (p)-W-S) derived from Human Pim-1.
- Isotype
- IgG
- Top Product
- Discover our top product PIM1 Anticorps primaire
-
-
- Indications d'application
- Western Blot: 1:500~1:1000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store antibody at -20°C for up to one year.
-
- Antigène
- PIM1 (Pim-1 Oncogene (PIM1))
- Autre désignation
- Pim-1 (PIM1 Produits)
- Synonymes
- anticorps PIM, anticorps Pim-1, anticorps PIM1, anticorps pim, anticorps pim-1, anticorps pim3, anticorps Pim-1 proto-oncogene, serine/threonine kinase, anticorps proviral integration site 1, anticorps Pim-1 proto-oncogene, serine/threonine kinase L homeolog, anticorps PIM1, anticorps Pim1, anticorps pim1, anticorps pim1.L
- Sujet
- Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity. The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis.
- Poids moléculaire
- 45 kDa
- ID gène
- 5292
- NCBI Accession
- NP_001230115
- UniProt
- P06803
- Pathways
- Glycosaminoglycan Metabolic Process
-